Breaking News English

New nasal spray treats emergency allergic reactions

Anaphylaxis - Level 0

The USA has a spray for emergency allergic reactions. Around 40 per cent of people have an allergy. Eleven per cent of people have a food allergy. These can kill people. Things like peanuts, milk and bee stings can cause low blood pressure. Some people get a swollen tongue. This makes breathing difficult. People can die.

The spray can be used instead of an injection. People spray the drug up their nose. This will help people who are afraid of injections and needles. The spray will help people who get a serious allergic reaction called anaphylaxis. The spray will be available in the USA. It is likely to be sold in other countries in the next few years.

SPEED READING

Speed 1    |     Speed 2    |     Speed 3

MORE

11 online activities    |    8-page printable   (PDF)

Anaphylaxis - Level 1

There is good news for people with allergies. The USA has a nasal spray to treat emergency allergic reactions. Up to 40 per cent of people have an allergy. Eleven per cent of people have a food allergy. These can be life-threatening. Allergens like peanuts, dairy products and bee stings can lead to anaphylaxis. People can suddenly experience low blood pressure. Some people get a swollen tongue, which makes breathing difficult. It can lead to death.

The nasal spray means people no longer need an injection. They spray the drug up their nose. A spokesperson said: "Anaphylaxis is life-threatening and some people…may delay or avoid treatment due to a fear of injections." She said the spray was an important drug for people who are afraid of needles. The spray will soon be available in the USA. It is likely to be sold in other countries in the near future.

SPEED READING

Speed 1    |     Speed 2    |     Speed 3

MORE

11 online activities    |    8-page printable   (PDF)

Anaphylaxis - Level 2

Slowest

There is good news for people with allergies. The USA has approved a nasal spray to treat emergency allergic reactions. Up to 40 per cent of people suffer from an allergy. Around 11 per cent of people have a food allergy. Allergies can cause a life-threatening condition called anaphylaxis. This is caused by allergens like peanuts, dairy products, bee stings, and other things. People who suffer anaphylactic shock can have different symptoms. These include low blood pressure and vomiting. Some people get a swollen tongue or throat. This can make breathing difficult and lead to death.

The nasal spray is called Neffy. It means people no longer need an injection. They spray the drug up their nose. Neffy is the first treatment of anaphylaxis that is not treated by an injection. A spokesperson said: "Anaphylaxis is life-threatening and some people, particularly children, may delay or avoid treatment due to a fear of injections." She added: "Neffy provides an important treatment option, and addresses an unmet need." Neffy will soon be available in the USA. It is likely to be sold in countries worldwide in the coming years.

SPEED READING

Speed 1    |     Speed 2    |     Speed 3

MORE

11 online activities    |    8-page printable   (PDF)

Anaphylaxis - Level 3

There is good news for people who have allergies. The Food and Drug Administration (FDA) in the USA has approved a nasal spray to treat emergency allergic reactions. The WHO says up to 40 per cent of people worldwide suffer from an allergy. Around 11 per cent of people have a food allergy. Allergies can cause a condition called anaphylaxis. This is life-threatening. Anaphylaxis is caused by allergens like peanuts, dairy products, bee stings, fresh fruit and many other things. People who suffer anaphylactic shock can have different symptoms. These include dangerously low blood pressure, vomiting or diarrhoea. Some people experience a swollen tongue and / or throat, which can cause trouble breathing and lead to death.

The new nasal spray is called Neffy. It means people no longer need an EpiPen injection. They simply spray the drug up their nose. This is welcome news for people who have a fear of needles. Neffy is the first treatment of anaphylaxis that is not treated by an injection. An FDA spokesperson said: "Anaphylaxis is life-threatening and some people, particularly children, may delay or avoid treatment due to a fear of injections. The availability of [the] nasal spray may reduce barriers to rapid treatment of anaphylaxis." She added: "Neffy provides an important treatment option, and addresses an unmet need." Neffy will initially be available in the USA. It is likely to be rolled out worldwide in the coming years.

SPEED READING

Speed 1    |     Speed 2    |     Speed 3

MORE

25 online activities    |    27-page printable    |    2-page mini-lesson